|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Cash flows from operating activities: | ||
| Net loss | ||
| Adjustments to reconcile net loss to net cash used in operations: | ||
| Stock-based compensation | ||
| Accretion of discounts on available-for-sale marketable securities | ||
| Non-cash lease expense | ||
| Depreciation and amortization expense | ||
| Impairment of capitalized software | ||
| Non-cash interest expense | ||
| Loss on disposal of property and equipment | ||
| Changes in assets and liabilities: | ||
| Prepaid expense and other current assets | ||
| Other non-current assets | ||
| Accounts payable | ||
| Accrued compensation | ||
| Other accrued expenses and current liabilities | ||
| Accrued license expense - related party | ||
| Operating lease liability | ||
| Net cash used in operating activities | ||
| Cash flows from investing activities | ||
| Purchases of available-for-sale marketable securities | ||
| Proceeds from maturities of available-for-sale marketable securities | ||
| Internal-use software development costs | ||
| Proceeds from sale of property and equipment | ||
| Purchases of property and equipment | ||
| Net cash provided by (used in) investing activities | ||
| Cash flows from financing activities | ||
| Proceeds from issuance of common stock upon initial public offering and underwritten public offering, net of underwriting commissions | ||
| Proceeds from issuance of common stock under the ATM Facility, net of agent's fees | ||
| Proceeds from borrowing of the term loan, net of issuance costs | ||
| Proceeds from exercise of common stock options | ||
| Principal paid on finance lease liabilities | ||
| Payments for common stock issuance offering costs | ||
| Taxes paid related to net share settlement upon vesting of restricted stock units | ||
| Net cash provided by financing activities | ||
| Net increase in cash and cash equivalents and restricted cash | ||
| Cash, cash equivalents and restricted cash, at beginning of period | ||
| Cash, cash equivalents and restricted cash, at end of period | ||
| Supplemental disclosure for non-cash investing and financing activities | ||
| Conversion of 114,556,997 shares of redeemable convertible preferred stock to common stock shares upon the closing of initial public offering | ||
| Unpaid offering costs included in accounts payable and other current liabilities | ||
| Vesting of restricted stock | ||
| Right-of-use asset obtained in exchange for operating and finance lease liability | ||
| Supplemental disclosure of cash flow information | ||
| Cash paid for interest | ||
| Reconciliation of cash, cash equivalents and restricted cash to statement of financial position | ||
| Cash and cash equivalents | ||
| Restricted cash |
Loading...
